Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Molecular Oncology|May 23, 2020
Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancerRoberta Roncarati, Laura Lupini, Elena Miotto, et al.
Molecular Therapy. Nucleic Acids|January 15, 2019
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver CancerElisa Callegari, Marco Domenicali, Ram Charan Shankaraiah, et al.
Hepatology (Baltimore, Md.)|April 5, 2012
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic modelElisa Callegari, Bahaeldin K Elamin, Ferdinando Giannone, et al.
Molecular Therapy. Nucleic Acids|June 3, 2018
miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse ModelElisa Callegari, Lucilla D'Abundo, Paola Guerriero, et al.
International Journal of Molecular Sciences|August 12, 2022
Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with "Oncogene-Addicted" Advanced Lung Adenocarcinoma: A Real-World Clinical StudyLaura Lupini, Roberta Roncarati, Lorenzo Belluomini, et al.
Frontiers in Immunology|September 8, 2025
Expressed mutated genes in Sezary syndrome and their potential prognostic value in patients treated with extracorporeal photopheresisCristina Cristofoletti, Giulia Salvatore, Cristian Bassi, et al.
Cell Death Discovery|January 19, 2026
Targeting metabolic vulnerabilities: REV-ERB agonist SR9009 potentiates sorafenib efficacy in liver cancerSilvia Sabbioni, Paola Guerriero, Ram C Shankaraiah, et al.
Genes, Chromosomes & Cancer|September 11, 2015
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlationsGian Matteo Rigolin, Ilaria del Giudice, Luca Formigaro, et al.
Oncotarget|April 11, 2018
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinomaFarzaneh Moshiri, Alessandro Salvi, Laura Gramantieri, et al.
Cells|April 27, 2026
Circulating miR-22 Early Predicts TACE Non-Response and Targets WEE1 in Hepatocellular CarcinomaLaura Gramantieri, Clara Vianello, Ilaria Leoni, et al.
Pageof 5